Coeptis Therapeutics Holdings Income Statement (2021-2025) | COEP

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.06M0.20M0.24M
Cost of Revenue 0.14M0.01M0.08M0.01M300.000.01M0.11M0.05M0.05M
Gross Profit 0.02M0.16M0.19M
Operating items
Amortization - Intangibles 0.25M0.25M
Research & Development 0.02M0.12M0.47M5.07M1.01M0.78M0.40M0.81M0.34M0.09M0.29M0.59M
Selling, General & Administrative 15.72M9.74M5.49M3.22M0.34M3.22M0.27M0.34M0.17M0.24M0.17M0.36M0.27M0.53M0.20M
Other Operating Expenses 0.07M0.06M-0.17M6.09M0.04M2.56M2.01M1.97M2.19M1.16M1.46M3.72M3.86M1.88M
Operating Expenses 15.72M9.81M5.57M3.04M6.54M3.73M7.90M3.37M2.92M2.83M2.14M2.16M4.07M4.68M2.67M
Operating Income -0.14M-15.72M-9.81M-5.57M-3.04M-6.54M-3.73M-7.90M-3.37M-2.92M-2.83M-2.14M-2.16M-4.06M-4.52M-2.48M
EBIT -0.14M-15.72M-9.81M-5.57M-3.04M-6.54M-3.73M-7.90M-3.37M-2.92M-2.83M-2.14M-2.16M-4.06M-4.52M-2.48M
Non-operating items
Interest & Investment Income 0.00M
Other Non Operating Income -3.41M0.02M2.27M35.001.61M-0.18M0.09M-0.15M0.35M-0.58M0.11M-0.34M0.15M
Non Operating Income 14.21M-3.46M0.01M-0.08M0.10M-1.42M0.53M1.55M-0.39M0.09M-0.21M0.31M-0.97M0.64M-0.34M-0.42M
Net income details
EBT -0.14M-19.18M-9.80M-5.65M-2.94M-7.96M-3.20M-6.35M-3.76M-3.00M-3.04M-1.83M-3.01M-3.42M-4.33M-2.90M
Profit After Tax 14.07M-19.18M-9.80M-5.65M-2.94M-7.96M-3.20M-6.35M17.51M-3.04M-1.83M-1.95M-3.06M-4.33M-2.90M
Income from Non-Controlling Interests 0.10M0.96M0.36M0.80M0.16M
Income from Continuing Operations -0.14M-19.18M-9.80M-5.65M-2.94M-7.96M-3.20M-6.35M-3.76M-3.00M-3.04M-1.83M-3.01M-3.42M-4.33M-2.90M
Consolidated Net Income -0.14M-19.18M-9.80M-5.65M-2.94M-7.96M-3.20M-6.35M-3.76M-3.00M-3.04M-1.83M-3.01M-3.42M-4.33M-2.90M
Income towards Parent Company -0.14M-19.18M-9.80M-5.65M-2.94M-7.96M-3.20M-6.35M-3.76M-3.00M-3.04M-1.83M-3.01M-3.42M-4.33M-2.90M
Net Income towards Common Stockholders -0.14M-19.18M-9.80M-5.65M-2.94M-7.96M-3.20M-6.35M-3.76M-3.00M-3.04M-1.83M-3.01M-3.42M-4.33M-2.90M
Additional items
EPS (Basic) -0.03-1.52-0.75-0.42-0.21-0.40-0.15-0.24-2.92-0.08-0.08-0.05-1.56-1.11-1.17-0.61
EPS (Weighted Average and Diluted) -1.52-0.75-0.42-0.21-0.40-0.15-0.24-2.92-0.08-0.08-0.05-1.56-1.11-1.17-0.61
Shares Outstanding (Weighted Average) 4.55M7.50M9.38M10.91M12.61M13.02M13.46M14.30M20.08M21.81M26.65M1.28M35.54M37.57M39.81M1.92M3.07M3.71M4.75M
Shares Outstanding (Diluted Average) 7.50M9.38M10.91M12.61M13.02M13.46M14.30M20.08M21.81M26.65M1.28M35.54M37.57M39.81M1.92M3.07M3.71M4.75M
EBITDA -0.14M-15.72M-9.81M-5.57M-3.04M-6.54M-3.73M-7.90M-3.37M-2.92M-2.83M-2.14M-2.16M-4.06M-4.52M-2.48M
Interest Expenses 0.06M0.06M0.06M0.14M0.03M0.04M0.02M0.01M0.20M0.07M0.05M0.08M0.07M0.07M0.06M